Jeff Cislini - 17 Oct 2025 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Signature
/s/ Jack Anders, as Attorney-in-fact for Jeff Cislini
Issuer symbol
RVMD
Transactions as of
17 Oct 2025
Net transactions value
-$221,160
Form type
4
Filing time
20 Oct 2025, 16:19:24 UTC
Previous filing
26 Sep 2025
Next filing
20 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cislini Jeff General Counsel C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY /s/ Jack Anders, as Attorney-in-fact for Jeff Cislini 20 Oct 2025 0001969082

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $438,840 +12,000 +24% $36.57 62,425 17 Oct 2025 Direct F1, F2
transaction RVMD Common Stock Sale $660,000 -12,000 -19% $55.00 50,425 17 Oct 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -12,000 -40% $0.000000 18,000 17 Oct 2025 Common Stock 12,000 $36.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025.
F2 Includes 43,910 restricted stock units.